• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Immunol . Proinflammatory IgG Fc structures in patients with severe COVID-19

tetano

Editor, Senior Moderator
Nat Immunol


. 2020 Nov 9.
doi: 10.1038/s41590-020-00828-7. Online ahead of print.
Proinflammatory IgG Fc structures in patients with severe COVID-19


Saborni Chakraborty[SUP] 1 [/SUP], Joseph Gonzalez[SUP] 1 [/SUP], Karlie Edwards[SUP] 1 [/SUP], Vamsee Mallajosyula[SUP] 2 [/SUP], Anthony S Buzzanco[SUP] 1 [/SUP], Robert Sherwood[SUP] 3 [/SUP], Cindy Buffone[SUP] 1 [/SUP], Nimish Kathale[SUP] 1 [/SUP], Susan Providenza[SUP] 1 [/SUP], Markus M Xie[SUP] 1 [/SUP], Jason R Andrews[SUP] 1 [/SUP], Catherine A Blish[SUP] 1 4 [/SUP], Upinder Singh[SUP] 1 5 [/SUP], Haley Dugan[SUP] 6 [/SUP], Patrick C Wilson[SUP] 6 [/SUP], Tho D Pham[SUP] 7 [/SUP], Scott D Boyd[SUP] 8 9 [/SUP], Kari C Nadeau[SUP] 9 [/SUP], Benjamin A Pinsky[SUP] 1 8 [/SUP], Sheng Zhang[SUP] 3 [/SUP], Matthew J Memoli[SUP] 10 [/SUP], Jeffery K Taubenberger[SUP] 10 11 [/SUP], Tasha Morales[SUP] 12 [/SUP], Jeffrey M Schapiro[SUP] 12 [/SUP], Gene S Tan[SUP] 13 14 [/SUP], Prasanna Jagannathan[SUP] 1 5 [/SUP], Taia T Wang[SUP] 15 16 17 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 infections can cause coronavirus disease 2019 (COVID-19), which manifests with a range of severities from mild illness to life-threatening pneumonia and multi-organ failure. Severe COVID-19 is characterized by an inflammatory signature, including high levels of inflammatory cytokines, alveolar inflammatory infiltrates and vascular microthrombi. Here we show that patients with severe COVID-19 produced a unique serologic signature, including an increased likelihood of IgG1 with afucosylated Fc glycans. This Fc modification on severe acute respiratory syndrome coronavirus 2 IgGs enhanced interactions with the activating Fcγ receptor FcγRIIIa; when incorporated into immune complexes, Fc afucosylation enhanced production of inflammatory cytokines by monocytes, including interleukin-6 and tumor necrosis factor. These results show that disease severity in COVID-19 correlates with the presence of proinflammatory IgG Fc structures, including afucosylated IgG1.
 
Back
Top Bottom